SARS-CoV-2 triggers the production of the antiviral protein IFN-γ, which is associated with fatigue, muscle ache and depression. New research shows that in Long COVID patients, IFN-y production ...

But what we were able to do is set up a phase II clinical trial in COVID-19. And this was 101 patients-- half treated with placebo, half treated with inhaled interferon beta given once daily for ...

such as interleukin-12 and interferon gamma, at the tumor site. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101). We will continue to ...